<?xml version="1.0" encoding="UTF-8"?>
<p>PVI has also shown value in treatment formulations. A large clinical trial for the use of 1.25% PVI ophthalmic solution in the treatment of pediatric conjunctivitis displayed efficacy in treatment of bacterial, chlamydial, and viral conjunctivitis.
 <xref rid="CIT0040" ref-type="bibr">40</xref> Interestingly, a clinical trial looking at 0.5% PVI (in combination with artificial tears at pH 4.2 for enhanced tolerability) for the treatment of adenoviral keratoconjunctivitis found faster recovery from disease at two weeks, with three drops administered thrice daily.
 <xref rid="CIT0034" ref-type="bibr">34</xref>
</p>
